世界睡眠医学杂志2024,Vol.11Issue(6) :1194-1197.DOI:10.3969/j.issn.2095-7130.2024.06.002

观察沙库巴曲缬沙坦及睡眠干预对心力衰竭伴失眠患者睡眠参数、心功能的影响

Observation of the Effects of Sacubitril Valsartan and Sleep Intervention on Sleep Parameters and Cardiac Function in Patients with Heart Failure and Insomnia

郑炳南 吴彬澜 钟康
世界睡眠医学杂志2024,Vol.11Issue(6) :1194-1197.DOI:10.3969/j.issn.2095-7130.2024.06.002

观察沙库巴曲缬沙坦及睡眠干预对心力衰竭伴失眠患者睡眠参数、心功能的影响

Observation of the Effects of Sacubitril Valsartan and Sleep Intervention on Sleep Parameters and Cardiac Function in Patients with Heart Failure and Insomnia

郑炳南 1吴彬澜 1钟康1
扫码查看

作者信息

  • 1. 福建省泉州市永春县医院,永春,362600
  • 折叠

摘要

目的:观察沙库巴曲缬沙坦及睡眠干预对心力衰竭伴失眠患者睡眠参数、心功能的影响.方法:选取2021年5月至2023年5月福建省泉州市永春县医院收治的心力衰竭伴失眠患者200例作为研究对象,按照随机数字表法分为对照组和观察组,每组100例.对照组患者给予常规治疗,观察组给予沙库巴曲缬沙坦及睡眠管理干预,采用SF-A30型多导睡眠监测仪检测患者觉醒时间、睡眠潜伏期、睡眠总时间、睡眠效率,采用E-CUBE 15型彩色超声诊断仪在治疗前、后检测左心室射血分数、E峰减速时间、左室质量指数,采用酶联免疫吸附试验法检测血清肿瘤坏死因子α(TNF-α)水平;治疗前、后抽取5 mL空腹肘静脉血,采用电化学发光法检测N末端B型利钠肽原(NT-proBNP)水平;采用放射免疫法检测血浆肾素活性(PRA)水平,并比较2组患者的临床疗效.结果:干预后,观察组患者觉醒时间、睡眠潜伏期显著短于对照组,观察组睡眠效率显著高于对照组,睡眠总时间显著长于对照组,观察组左心室射血分数显著高于对照组,观察组E峰减速时间、左室质量指数较对照组低,观察组TNF-α、NT-proBNP、PRA含量较对照组低,观察组总有效率显著高于对照组,差异均有统计学意义(均P<0.05).结论:沙库巴曲缬沙坦及睡眠干预治疗心力衰竭伴失眠患者,可抑制炎症,改善心功能、心室重塑、睡眠参数,提升睡眠质量及临床疗效,值得临床推广应用.

Abstract

Objective:To observe the effects of sacubitril valsartan and sleep intervention on sleep parameters and cardiac func-tion in patients with heart failure and insomnia.Methods:A total of 200 patients with heart failure and insomnia in the fingers of Yongchun County Hospital,Quanzhou City,Fujian Province from May 2021 to May 2023 were selected as the study subjects.They were randomly divided into a control group and an observation group,with 100 cases in each group,using a random number table method.The control group received routine treatment,while the observation group received sacubitril valsartan and sleep manage-ment intervention.The SF-A30 multi-channel sleep monitor was used to detect the patient's awakening time,sleep latency,total sleep time,and sleep efficiency.The E-CUBE 15 color ultrasound diagnostic instrument was used to detect left ventricular ejection fraction,E-peak deceleration time,and left ventricular mass index before and after treatment.The serum tumor necrosis factor al-pha(TNF-alpha)level was measured using enzyme-linked immunosorbent assay;5 mL of fasting elbow vein blood was extracted before and after treatment,and the N-terminal B-type pronatriuretic peptide(NT proBNP)level was detected using electrochem-iluminescence method;Using radioimmunoassay to detect plasma renin activity(PRA)levels and comparing the clinical efficacy of two groups of patients.Results:After intervention,the awakening time and sleep latency of the observation group were signifi-cantly shorter than those of the control group.The sleep efficiency of the observation group was significantly higher than that of the control group,and the total sleep time was significantly longer.The left ventricular ejection fraction of the observation group was significantly higher than that of the control group.The E peak deceleration time and left ventricular mass index of the observation group were lower than those of the control group.The TNF-α,NT proBNP,and PRA content of the observation group were lower than those of the control group.The total effective rate of the observation group was significantly higher than that of the control group,and the differences between the two groups were statistically significant(P<0.05).Conclusion:Sacubitril valsartan and sleep intervention can inhibit inflammation,improve heart function,ventricular remodeling,sleep parameters,enhance sleep quality and clinical efficacy in patients with heart failure and insomnia.It is worthy of clinical promotion and application.

关键词

沙库巴曲缬沙坦/睡眠干预/心力衰竭/失眠/炎症/心功能/睡眠参数

Key words

Sacubitril and valsartan/Sleep intervention/Heart failure/Insomnia/Inflammation/Heart function/Sleep parame-ters

引用本文复制引用

出版年

2024
世界睡眠医学杂志

世界睡眠医学杂志

ISSN:
参考文献量15
段落导航相关论文